Startup India Government of India
Solitaire Pharmaceuticals Private Limited
Solitaire Pharmaceuticals Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹7.79 Cr
▲ 430% YoY
Net profit · FY 2025
₹17.06 Lakh
Net margin 2.2%
EBITDA · FY 2025
₹1.25 Cr
EBITDA margin 16.1%
Authorised capital
₹1.28 Cr
Registered with MCA
Paid-up capital
₹1.28 Cr
Issued & subscribed
Open charges
₹4.6 Cr
Secured borrowings
Company age
4 yrs
Est. 2022
Directors on board
3
As per MCA filings
About Solitaire Pharmaceuticals Private Limited
Data last updated:
Solitaire Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 August 2022.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24290GJ2022PTC134510.
The company has an authorised share capital of ₹1.28 Cr and a paid-up capital of ₹1.28 Cr. It is led by directors including Shailesh R Gor and Vedant Shailesh Gor.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 24 Vrudavan Vihar Soc B/H Smruti Mandir Ghodasar, Ahmedabad, Gujarat, India – 380050.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.79 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹17.06 Lakh (net margin 2.2%) and EBITDA of ₹1.25 Cr (EBITDA margin 16.1%).
As per MCA filings, the company has open charges of ₹4.6 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24290GJ2022PTC134510
Registration Number 134510
Incorporation Date 04 August 2022
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Solitaire Pharmaceuticals
Contact details
Solitaire Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address24 Vrudavan Vihar Soc B/H Smruti Mandir Ghodasar, Ahmedabad, Gujarat, India – 380050
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Solitaire Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Solitaire Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Solitaire Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Solitaire Pharmaceuticals Private Limited, buy the company report.
Financials of Solitaire Pharmaceuticals Private Limited
FY 2025 filings availableSolitaire Pharmaceuticals Private Limited reported revenue of ₹7.79 Cr (up 430% YoY) for FY 2025.
Revenue · FY 2025
₹7.79 Cr ▲ 430%
Net profit · FY 2025
₹17.06 Lakh margin 2.2%
EBITDA · FY 2025
₹1.25 Cr margin 16.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 430%
EBITDA CAGR growth
1 year
▲ 162%
Revenue rose 430% in the latest year. EBITDA rose 162% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1.25 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹17.06 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 16.1% | ||
| Net Profit Margin | 2.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Solitaire Pharmaceuticals Private Limited, buy the company report.
Board of directors of Solitaire Pharmaceuticals Private Limited
Solitaire Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shailesh R Gor | Director | 04 Aug 2022 | 4 Years 2 Months | Current |
| Vedant Shailesh Gor | Director | 04 Aug 2022 | 4 Years 2 Months | Current |
| Urvang Shailesh Gor | Director | 04 Aug 2022 | 4 Years 2 Months | Current |
Peer comparison
Solitaire Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bennevolance Pharma Private Limited | ₹7.82 Cr (FY 2025) | 16.0% | Ahmedabad, Gujarat, India | |||
| Aeron Lifescience Private Limited | ₹7.82 Cr (FY 2025) | 0.0% | Ahmedabad, Gujarat, India | |||
| Dermiderm Biotech Private Limited | ₹7.81 Cr (FY 2023) | 12864.0% | Panchkula, Haryana, India | |||
| Lumen Pharmachem Private Limited | ₹7.81 Cr (FY 2024) | -12.0% | Mehsana, Gujarat, India | |||
| Intact Drugs and Pharmaceuticlas Pvt.Ltd. | ₹7.8 Cr (FY 2025) | -54.0% | Delhi, India | |||
| Solitaire Pharmaceuticals Private Limitedthis company | ₹7.79 Cr (FY 2025) | ₹17.06 Lakh | 2.2% | 430.0% | Ahmedabad, Gujarat, India | |
| Purica Pharmaceuticals Private Limited | ₹7.76 Cr (FY 2025) | -1.0% | Kalol, Gujarat, India |
To see the full peer comparison of Solitaire Pharmaceuticals Private Limited, buy the company report.
Auditor
Solitaire Pharmaceuticals Private Limited is audited by MANISH DEVENDRABHAI DAVE for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANISH DEVENDRABHAI DAVE | FY 2023 | 105359 |
Shareholding
The shareholding of Solitaire Pharmaceuticals Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Solitaire Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.6 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Sep 2023 | 100782608 | Others | ₹4.6 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Solitaire Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Solitaire Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Solitaire Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 30, 2024.
Active EPFO establishments
1
GST
No GST registration is on our record for Solitaire Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Solitaire Pharmaceuticals Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Shailesh R Gor was appointed as Director on 04 Aug 2022.
AGM
Solitaire Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Solitaire Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Others amounted to Rs. 4.60 Cr with Charge ID 100782608 was registered on 16 Sep 2023.
Appointed
Shailesh R Gor was appointed as Director.
Appointed
Urvang Shailesh Gor was appointed as Director.
Appointed
Vedant Shailesh Gor was appointed as Director.
Incorporation
04 Aug 2022
Solitaire Pharmaceuticals Private Limited was registered on 04 Aug 2022 with Roc Ahmedabad & aged 4 years 3 months as per MCA records.
Frequently asked questions
Solitaire Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 August 2022 (4+ years old) and is registered under CIN U24290GJ2022PTC134510.
Solitaire Pharmaceuticals has 3 current directors:
- Shailesh R Gor - Director
- Vedant Shailesh Gor - Director
- Urvang Shailesh Gor - Director
The latest financial statements of Solitaire Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Solitaire Pharmaceuticals is U24290GJ2022PTC134510. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Solitaire Pharmaceuticals was incorporated on 04 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Solitaire Pharmaceuticals by revenue are Bennevolance Pharma Private Limited, Aeron Lifescience Private Limited, Dermiderm Biotech Private Limited, Lumen Pharmachem Private Limited, Intact Drugs and Pharmaceuticlas Pvt.Ltd. and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Shailesh R Gor was appointed as Director on 04 Aug 2022. Urvang Shailesh Gor was appointed as Director on 04 Aug 2022. Vedant Shailesh Gor was appointed as Director on 04 Aug 2022.
Yes, Solitaire Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Solitaire Pharmaceuticals is at 24 Vrudavan Vihar Soc BH Smruti Mandir Ghodasar, Ahmedabad, Gujarat, India – 380050.
Solitaire Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Solitaire Pharmaceuticals has open charges of ₹4.6 Cr and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages